DRUG · Mapped RxNorm record
Selinexor
Normalized identity: selinexorView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
NCT04984330
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Dexamethasone
Normalized identity: dexamethasoneView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSelinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Amyloidverified · MONDO: amyloidosis
Amyloidosisverified · MONDO: amyloidosis
AL Amyloidosisverified · MONDO: AL amyloidosis
Interventions
SelinexorDRUG · verified · RxNorm: selinexor
DexamethasoneDRUG · verified · RxNorm: dexamethasone
Sponsors & collaborators
Weill Medical College of Cornell Universitylead sponsor
Karyopharm Therapeutics Inccollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04984330 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.